Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Fujii

Showing results (471-480 of 518) with videos related to

Pageof 52
Sort By:
Blood|April 29, 2004
Natural killer T cells accelerate atherogenesis in miceYukihito Nakai, Kazuya Iwabuchi, Satoshi Fujii, et al.
Genome Medicine|November 27, 2025
Characterizing heterogeneous cis-regulatory elements in gene regulatory programs associated with breast cancerChisa Hori, Kohei Kumegawa, Sumito Saeki, et al.
International Journal of Clinical Oncology|April 10, 2026
Predicting pathological lymph node status in clinical stage I/II tongue cancerYusuke Nojima, Natsumi Kijima, Daisuke Sano, et al.
Digestion|December 17, 2018
The Incidence and Risk Factors of Venous Thromboembolism in Patients with Inflammatory Bowel Disease: A Prospective Multicenter Cohort StudyKatsuyoshi Ando, Mikihiro Fujiya, Yoshiki Nomura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Rapid Screening Using Pathomorphologic Interpretation to Detect BRAFV600E Mutation and Microsatellite Instability in Colorectal CancerSatoshi Fujii, Daisuke Kotani, Masahiro Hattori, et al.
Lung Cancer (Amsterdam, Netherlands)|July 12, 2020
Association between the mutational smoking signature and the immune microenvironment in lung adenocarcinomaKei Sato, Sachiyo Mimaki, Riu Yamashita, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 20, 2022
Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenograftingYoshihiro Aizawa, Kentaro Takada, Jun Aoyama, et al.
JCO Precision Oncology|January 17, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH TrialMitsuho Imai, Yoshiaki Nakamura, Sangwon Shin, et al.
Neuro-Oncology Advances|March 9, 2026
<i>BRAF</i>-mutant high-grade glioma with pleomorphic and pseudopapillary features (HPAP): A PLNTY mimic demonstrating tumor progression during longitudinal follow-upYutaro Takayama, Mariko Yaegashi, Kaishi Satomi, et al.
ESMO Open|February 8, 2021
BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancerDaisuke Kotani, Hideaki Bando, Hiroya Taniguchi, et al.
Pageof 52

Showing results (471-480 of 518) with videos related to

Sort By:
Pageof 52
Blood|April 29, 2004
Natural killer T cells accelerate atherogenesis in miceYukihito Nakai, Kazuya Iwabuchi, Satoshi Fujii, et al.
Genome Medicine|November 27, 2025
Characterizing heterogeneous cis-regulatory elements in gene regulatory programs associated with breast cancerChisa Hori, Kohei Kumegawa, Sumito Saeki, et al.
International Journal of Clinical Oncology|April 10, 2026
Predicting pathological lymph node status in clinical stage I/II tongue cancerYusuke Nojima, Natsumi Kijima, Daisuke Sano, et al.
Digestion|December 17, 2018
The Incidence and Risk Factors of Venous Thromboembolism in Patients with Inflammatory Bowel Disease: A Prospective Multicenter Cohort StudyKatsuyoshi Ando, Mikihiro Fujiya, Yoshiki Nomura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Rapid Screening Using Pathomorphologic Interpretation to Detect BRAFV600E Mutation and Microsatellite Instability in Colorectal CancerSatoshi Fujii, Daisuke Kotani, Masahiro Hattori, et al.
Lung Cancer (Amsterdam, Netherlands)|July 12, 2020
Association between the mutational smoking signature and the immune microenvironment in lung adenocarcinomaKei Sato, Sachiyo Mimaki, Riu Yamashita, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 20, 2022
Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenograftingYoshihiro Aizawa, Kentaro Takada, Jun Aoyama, et al.
JCO Precision Oncology|January 17, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH TrialMitsuho Imai, Yoshiaki Nakamura, Sangwon Shin, et al.
Neuro-Oncology Advances|March 9, 2026
<i>BRAF</i>-mutant high-grade glioma with pleomorphic and pseudopapillary features (HPAP): A PLNTY mimic demonstrating tumor progression during longitudinal follow-upYutaro Takayama, Mariko Yaegashi, Kaishi Satomi, et al.
ESMO Open|February 8, 2021
BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancerDaisuke Kotani, Hideaki Bando, Hiroya Taniguchi, et al.
Pageof 52